24
total announcements
GLAXO.NS · 15 min delayed
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and listing of new securities on stock exchanges.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has held its 101st Annual General Meeting on June 30, 2026, and has announced the voting results for various resolutions. The company has approved all the resolutions, including the appointment of a new director, declaration of dividend, and ratification of remuneration to auditors. The voting results are available on the company's website and the National Securities Depository Limited's website.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has received a Demand Notice from the National Pharmaceutical Pricing Authority for overcharging Rs. 1,22,91,163 and interest of Rs. 2,31,20,862, totaling Rs. 3,54,12,025. The company will file an appeal against the demand order.